title: Oral Fusobacterium nucleatum subsp. polymorphum binds to human salivary α-amylase.
abstract: Fusobacterium nucleatum acts as an intermediate between early and late colonizers in the oral cavity. In this study, we showed that F. nucleatum subsp. polymorphum can bind to a salivary component with a molecular weight of approximately 110 kDa and identified the protein and another major factor of 55 kDa, as salivary α-amylase by time-of-flight mass spectrometry and immuno-reactions. Salivary α-amylase is present in both monomeric and dimeric forms and we found that formation of the dimer depends on copper ions. The F. nucleatum adhered to both monomeric and dimeric salivary α-amylases, but the numbers of bacteria bound to the dimeric form were more than those bound to the monomeric form. The degree of adherence of F. nucleatum to four α-amylases from different sources was almost the same, however its binding to β-amylase was considerably decreased. Among four α-amylase inhibitors tested, acarbose and type 1 and 3 inhibitors derived from wheat flour showed significant activity against the adhesion of F.nucleatum to monomeric and dimeric amylases, however voglibose had little effect. Moreover F. nucleatum cells inhibited the enzymatic activity of salivary α-amylase in a dose-dependent manner. These results suggest that F. nucleatum plays more important and positive role as an early colonizer for maturation of oral microbial colonization.
authors.affiliation: Department of Preventive Dentistry, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Zulfiqar
authors.forename: T
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: S
authors.initials: S
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Oho
mesh_terms: D020909:Acarbose / Q000494:pharmacology; D001422:Bacterial Adhesion / Q000502:physiology*; D004800:Enzymes, Immobilized; D005674:Fusobacterium Infections / Q000517:prevention & control; D016967:Fusobacterium nucleatum / Q000378:metabolism* / Q000502:physiology; D065089:Glycoside Hydrolase Inhibitors / Q000494:pharmacology; D006801:Humans; D007294:Inositol / Q000031:analogs & derivatives / Q000494:pharmacology; D010510:Periodontal Diseases / Q000517:prevention & control; D012463:Saliva / Q000201:enzymology; D055291:Salivary alpha-Amylases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D001614:beta-Amylase / Q000378:metabolism
chemical_list: D004800:Enzymes, Immobilized; D065089:Glycoside Hydrolase Inhibitors; D007294:Inositol; D055291:Salivary alpha-Amylases; D001614:beta-Amylase; C102817:voglibose; D020909:Acarbose
keywords: anaerobes; biofilms; oral microbiology; peridontal disease